Back
Grace Therapeutics, Inc. 10K Form
Sell
44
GRCE
Grace Therapeutics, Inc.
Last Price:
$3.47
Seasonality Move:
-16.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GRCE News And Ratings
See the #1 stock for the next 7 days that we like better than GRCE
GRCE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.45 |
| Price / Book: | 0.83 |
Profitability
| EPS (TTM): | -0.58470 |
|---|---|
| Net Income (TTM): | $-7.8M |
| Gross Margin: | $-7K |
| Return on Equity: | -12.98% |
| Return on Assets: | -11.36% |
Grace Therapeutics, Inc. Earnings Forecast
Key Grace Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 16 years have been positive in 9 years.
Grace Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | GRCE |
| Website: | gracetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.89 |
| Quick Ratio: | 13.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GRCE Technical Analysis vs Fundamental Analysis
Sell
44
Grace Therapeutics, Inc. (GRCE)
is a Sell
Is Grace Therapeutics, Inc. a Buy or a Sell?
-
Grace Therapeutics, Inc. stock is rated a SellThe current Grace Therapeutics, Inc. [GRCE] share price is $3.35. The Score for GRCE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.